(Q53219335)
Statements
Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines (English)
Whitehouse PJ
Orgogozo JM
Becker RE
Gauthier S
Pontecorvo M
Erzigkeit H
Rogers S
Mohs RC
Bodick N
Bruno G